Ubs Group Ag Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $5.84 Million - $6.85 Million	5,700 Added 5.86%	102,900 $108 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $17.5 Million - $21.2 Million	-19,800 Reduced 16.92%	97,200 $102 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $18.9 Million - $20.8 Million	-20,900 Reduced 15.16%	117,000 $113 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $9.38 Million - $10.7 Million	12,100 Added 9.62%	137,900 $121 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $15.1 Million - $18.4 Million	21,800 Added 20.96%	125,800 $104 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $10.7 Million - $12.7 Million	-15,300 Reduced 12.82%	104,000 $74.7 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $27.5 Million - $33.4 Million	-40,400 Reduced 25.3%	119,300 $98 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $847,068 - $919,668	1,200 Added 0.76%	159,700 $115 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $2.18 Million - $2.75 Million	-3,800 Reduced 2.34%	158,500 $109 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $7.57 Million - $10.2 Million	13,800 Added 9.29%	162,300 $95.9 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $8.63 Million - $10.1 Million	14,500 Added 10.82%	148,500 $104 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $27.9 Million - $34.5 Million	51,387 Added 62.2%	134,000 $84.6 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $4.13 Million - $4.9 Million	7,200 Added 9.55%	82,613 $50 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $2.74 Million - $3.24 Million	5,800 Added 8.33%	75,413 $42.1 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $18.8 Million - $23.1 Million	42,113 Added 153.14%	69,613 $32.9 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $14.9 Million - $17.6 Million	-40,000 Reduced 59.26%	27,500 $11.3 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $351,140 - $408,510	1,000 Added 1.5%	67,500 $27.3 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $28,460 - $34,499	100 Added 0.15%	66,500 $22.9 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $126,328 - $157,512	400 Added 0.61%	66,400 $22.9 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $8.25 Million - $10.8 Million	23,000 Added 53.49%	66,000 $24.8 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $9.92 Million - $11.6 Million	-23,000 Reduced 34.85%	43,000 $19.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,900 Added 53.13%	66,000 $32.4 Million
Q1 2017 Nov 14, 2017	BUY	N/A	43,100	43,100 $16.7 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account